Zhuxing Sun

Zhuxing Sun

Auto-generated profile, based on publicly available information

Zhuxing Sun

Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214000, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
QZQiuhua Zhang
Qiuhua Zhang
BHBiao Huang
Biao Huang
XLXiaobin Liu
Xiaobin Liu
BLBin Liu
Bin Liu
YZYi Zhang
Yi Zhang
ZSZhuxing Sun
Zhuxing Sun
Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is highly sensitive and quantitative for measuring serum PLA2R-Ab immunoglobulin (IgG). We measured PLA2R-Ab levels with TRFIA in sera from 172 patients with IMN (n = 69), secondary MN (n = 9), and those with other glomerulonephritis (n = 94) at the time of renal biopsy compared to healthy controls (n = 286). Serum anti-PLA2R-IgG levels in healthy volunteers ranged from 0.09–0.91 mg/L. We set the cutoff value of the anti-PLA2R-IgG titer at 0.91 mg/L, with a sensitivity of 84.06% for diagnosing IMN. Increasing the cut-off value to 2.025 mg/L altered the sensitivity for diagnosing IMN to 71.01%, but with 100% specificity. IMN patients had significantly higher serum anti-PLA2R-IgG levels compared to those with secondary MN. PLA2R-Ab titers negatively correlated with estimated glomerular filtration rate (eGFR). Patinets with high titers had significantly lower serum albumin and eGFR, higher proteinuria and serum creatinine levels, accompanied by a lower complete remission rate. High titers of PLA2R-Ab were associated with poor prognosis of patients with IMN. TRFIA-based quantification of anti-PLA2R-IgG can be a reliable approach for the diagnosis and prognostication of patients with IMN.

1 November 2019 in Medicine
Verified
Journal Article
Open access
QZQiuhua Zhang
Qiuhua Zhang
XLXiaobin Liu
Xiaobin Liu
ZZZhijian Zhang
Zhijian Zhang
MWMian Wu
Mian Wu
BHBiao Huang
Biao Huang
ZSZhuxing Sun
Zhuxing Sun
Patients with idiopathic membranous nephropathy (IMN) can be categorized into phospholipase A2 receptor (PLA2R)-associated and non-PLA2R-associated cases, according to serum PLA2R antibody status. The present study aimed to determine whether clinical features differed between these. A total of 89 patients with IMN were retrospectively recruited for the present study. Serum PLA2R-Ab levels were determined by time-resolved fluoroimmunoassay. Furthermore, the relationship between serum PLA2R antibody levels and their responses to immunosuppressants among patients with a complete follow-up period, which was defined as at least 1 year, was analyzed. Among these enrollees, 71 (80.0%) patients were positive for serum PLA2R antibody. Furthermore, patients with PLA2R-associated IMN had significantly higher age (with vs without, 54.31 ± 14.03 vs 46.67 ± 13.30 years old; P = .04), proteinuria (4.32 ± 1.84 vs 3.29 ± 1.90 g/d, P = .039), and serum albumin (25.33 ± 9.60 vs 31.38 ± 9.52 g/L, P = .019), but had lower serum immunoglobulin G (6.83 ± 2.89 vs 8.72 ± 2.95 g/L, P = .016) and erythrocyte sedimentation rate (47.31 ± 32.11 vs 26.33 ± 27.94, P = .013), when compared to IMN patients without PLA2R. Furthermore, IMN patients without PLA2R exhibited a better response to immunosuppressants, when compared to patients with PLA2R-associated IMN (without vs with, 66.7% vs 62.5% at 6 months and 100% vs 87.5% at 12 months), but the difference was not statistically significant. Patients with PLA2R-associated IMN had higher disease severity than IMN patients without PLA2R. Furthermore, PLA2R negative patients had a better response to immunosuppressive therapies than PLA2R-positive patients, but the difference was not statistically significant.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QZQiu-Hua Zhang
Qiu-Hua Zhang
MWMian Wu
Mian Wu
ZHZhigang Hu
Zhigang Hu
XLXiaobin Liu
Xiaobin Liu
BHBiao Huang
Biao Huang
ZSZhu-Xing Sun
Zhu-Xing Sun
Background. M‐type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible for idiopathic membranous nephropathy (IMN). However, serum PLA2R antibody (PLA2R‐Ab) can be inaccurate in distinguishing between IMN and secondary membranous nephropathy, while renal PLA2R antigen (PLA2R‐Ag) emerges as an ancillary diagnostic. The present study is aimed at examining the associations between PLA2R‐Ab in sera and PLA2R‐Ag in kidneys in IMN patients. Methods. A total of 93 patients with IMN were retrospectively identified. Their serum PLA2R‐Ab and renal PLA2R‐Ag expression levels were determined, and the clinical correlations between these parameters and clinical features were examined. Results. The sensitivities of serum PLA2R‐Ab and renal PLA2R‐Ag for diagnosing IMN were 74.2% and 88.2%, respectively (P < 0.001), with poor consistency. Higher serum PLA2R‐Ab levels were correlated to stronger renal PLA2R‐Ag expression (P = 0.048). Patients with positive PLA2R‐Ab significantly differed from those with negative levels, in terms of proteinuric levels over 24 hours (4.54 vs. 3.46 g/day, P = 0.015) and serum albumin (23.28 vs. 27.95 g/L, P = 0.038). Among patients with positive renal PLA2R‐Ag, patients with positive PLA2R‐Ab had significantly higher 24‐hour proteinuria, when compared to patients with negative PLA2R‐Ab (4.57 vs. 3.08 g/day, P = 0.005). Among those with positive PLA2R‐Ab in sera, their PLA2R‐Ab levels were correlated with the estimated glomerular filtration and serum creatinine. Conclusion. Serum PLA2R‐Ab exhibits a closer correlation with proteinuric severity and renal function, when compared to renal PLA2R‐Ag.